Healthcare provider profile · identity verified

Marc J Yunis

Nephrology · NEW HYDE PARK, NY · NPI 1790728434

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	156
Amlodipine Besylate	Amlodipine Besylate	505	137
Losartan Potassium	Losartan Potassium	387	108
Rosuvastatin Calcium	Rosuvastatin Calcium	333	106
Metoprolol Succinate	Metoprolol Succinate	331	98
Levothyroxine Sodium	Levothyroxine Sodium	268	70
Pantoprazole Sodium	Pantoprazole Sodium	206	71
Simvastatin	Simvastatin	191	53
Hydrochlorothiazide	Hydrochlorothiazide	184	57
Metformin Hcl	Metformin Hcl	163	48
Zolpidem Tartrate	Zolpidem Tartrate	148	25
Allopurinol	Allopurinol	140	40
Tamsulosin Hcl	Tamsulosin Hcl	137	40
Eliquis	Apixaban	136	34
Alprazolam	Alprazolam	127	30
Gabapentin	Gabapentin	124	32
Prednisone	Prednisone	106	51
Furosemide	Furosemide	103	37
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	103	32
Lisinopril	Lisinopril	100	31
Jardiance	Empagliflozin	97	32
Atenolol	Atenolol	93	25
Potassium Chloride	Potassium Chloride	92	28
Fluticasone Propionate	Fluticasone Propionate	85	33
Metformin Hcl Er	Metformin Hcl	84	24
Telmisartan	Telmisartan	84	21
Escitalopram Oxalate	Escitalopram Oxalate	80	21
Klor-Con M20	Potassium Chloride	80	27
Omeprazole	Omeprazole	78	28
Synthroid	Levothyroxine Sodium	78	21
Metoprolol Tartrate	Metoprolol Tartrate	70	19
Glimepiride	Glimepiride	66	20
Ozempic	Semaglutide	66	suppressed
Sertraline Hcl	Sertraline Hcl	65	18
Albuterol Sulfate Hfa	Albuterol Sulfate	64	27
Montelukast Sodium	Montelukast Sodium	64	20
Paroxetine Hcl	Paroxetine Hcl	63	14
Ramipril	Ramipril	62	18
Farxiga	Dapagliflozin Propanediol	61	17
Famotidine	Famotidine	59	23
Valsartan	Valsartan	58	21
Colchicine	Colchicine	56	15
Azithromycin	Azithromycin	55	46
Breo Ellipta	Fluticasone/Vilanterol	55	22
Ezetimibe	Ezetimibe	55	18
Clopidogrel	Clopidogrel Bisulfate	54	19
Finasteride	Finasteride	51	15
Chlorthalidone	Chlorthalidone	49	11
Enalapril Maleate	Enalapril Maleate	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	16
Pravastatin Sodium	Pravastatin Sodium	40	11
Diazepam	Diazepam	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	11
Clonazepam	Clonazepam	37	13
Januvia	Sitagliptin Phosphate	37	suppressed
Methylprednisolone	Methylprednisolone	37	29
Nifedipine Er	Nifedipine	37	suppressed
Xarelto	Rivaroxaban	36	suppressed
Amoxicillin	Amoxicillin	34	24
Labetalol Hcl	Labetalol Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	12
Mirtazapine	Mirtazapine	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	14
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Lactulose	Lactulose	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Folic Acid	Folic Acid	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Ammonium Lactate	Ammonium Lactate	15	suppressed
Naproxen	Naproxen	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Atovaquone	Atovaquone	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Clonidine	Clonidine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Flector	Diclofenac Epolamine	11	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error